[Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy].

Agaimy, A; Schneider-Stock, R

[Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy]. / Gastrointestinale Stromatumoren : Evolution eines Tumorkonzepts von unklassifizierbaren Neoplasien zur zielgerichteten molekularen Therapie.

Agaimy, A; Schneider-Stock, R.

Affiliation

Agaimy A; Pathologisches Institut, Universitätsklinikum Erlangen, Krankenhausstr. 12, 91054, Erlangen, Deutschland. abbas.agaimy@uk-erlangen.de

Pathologe ; 31(2): 115-22, 2010 Mar.

Article in De | MEDLINE | ID: mdl-19949796

Subject(s)

Antineoplastic Agents/therapeutic use; Drug Delivery Systems; Gastrointestinal Stromal Tumors/pathology; Indoles/therapeutic use; Piperazines/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Pyrimidines/therapeutic use; Pyrroles/therapeutic use; Benzamides; DNA Mutational Analysis; Gastrointestinal Stromal Tumors/drug therapy; Gastrointestinal Stromal Tumors/genetics; Gastrointestinal Tract/pathology; Gene Expression Regulation, Neoplastic/drug effects; Humans; Imatinib Mesylate; Prognosis; Proto-Oncogene Proteins c-kit/genetics; Receptor, Platelet-Derived Growth Factor alpha/genetics; Sequence Analysis, DNA; Sunitinib

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Pyrroles / Protein-Tyrosine Kinases / Drug Delivery Systems / Gastrointestinal Stromal Tumors / Indoles / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: De Journal: Pathologe Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google